ERK1/2-

Guangying Guo1, Juan Long1, Tianhua Xu1

  • 1Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.

Scientific reports
|September 30, 2025
PubMed
概括

补充剂通过减少血管化,改善慢性病矿物质骨疾病 (CKD-MBD). 它增强了自和骨代谢,为CKD并发症提供了潜在的治疗策略.